NQCCX
Price
$3.61
Change
-$0.00 (-0.00%)
Updated
May 22 closing price
Net Assets
21.39M
VIVAX
Price
$66.01
Change
-$0.28 (-0.42%)
Updated
May 22 closing price
Net Assets
183.65B
Interact to see
Advertisement

NQCCX vs VIVAX

Header iconNQCCX vs VIVAX Comparison
Open Charts NQCCX vs VIVAXBanner chart's image
Nuveen Large Cap Value Opportunities C
Price$3.61
Change-$0.00 (-0.00%)
VolumeN/A
Net Assets21.39M
Vanguard Value Index I
Price$66.01
Change-$0.28 (-0.42%)
VolumeN/A
Net Assets183.65B
NQCCX vs VIVAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
NQCCX vs. VIVAX commentary
May 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NQCCX is a Buy and VIVAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIVAX has more cash in the bank: 184B vs. NQCCX (21.4M). VIVAX pays higher dividends than NQCCX: VIVAX (2.22) vs NQCCX (1.12). NQCCX was incepted earlier than VIVAX: NQCCX (18 years) vs VIVAX (33 years). NQCCX (2.36) is less costly to investors than VIVAX (0.17). NQCCX is a more actively managed with annual turnover of: 35.00 vs. VIVAX (9.00). NQCCX has a lower initial minimum investment than VIVAX: NQCCX (2500) vs VIVAX (3000). VIVAX annual gain was more profitable for investors over the last year : 4.71 vs. NQCCX (2.28). VIVAX return over 5 years is better than : 75.18 vs. NQCCX (24.60).
NQCCXVIVAXNQCCX / VIVAX
Total Expense Ratio1.750.171,029%
Annual Report Gross Expense Ratio2.360.171,388%
Fund Existence18 years33 years-
Gain YTD1.1200.375299%
Front LoadN/AN/A-
Min. Initial Investment2500300083%
Min. Initial Investment IRAN/AN/A-
Net Assets21.4M184B0%
Annual Yield % from dividends1.122.2250%
Returns for 1 year2.284.7148%
Returns for 3 years19.5421.9789%
Returns for 5 years24.6075.1833%
Returns for 10 years-67.7797.35-70%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
EQH52.130.29
+0.56%
Equitable Holdings
TGNA16.74N/A
N/A
TEGNA
FLGT20.28N/A
N/A
Fulgent Genetics
OFS8.29-0.15
-1.78%
OFS Capital Corp
ENSC2.17-0.06
-2.91%
Ensysce Biosciences